Proposal for Creating a Guideline for Cancer Registration of Microinvasive Tumors of the Breast and Ovary (II)
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Cancer registration in Korea has a longer than 30-years of history, during which time cancer registration has improved and become well-organized. Cancer registries are fundamental for cancer control and multi-center collaborative research. However, there have been discrepancies in assigning behavior codes. Thus, we intend to propose appropriate behavior codes for the International Classification of Disease Oncology, 3rd edition (ICD-O-3) for microinvasive tumors of the ovary and breast not only to improve the quality of the cancer registry but also to prevent conflicts. Methods: As in series I, two pathology study groups and the Cancer Registration Committee of the Korean Society of Pathologists (KSP) participated. To prepare a questionnaire on provisional behavior code, the relevant subjects were discussed in the workshop, and consensus was obtained by convergence of opinion from members of KSP. Results: Microinvasive tumor of the breast should be designated as a microinvasive carcinoma which was proposed as malignant tumor (/3). Serous borderline tumor with microinvasion of the ovary was proposed as borderline tumor (/1), and mucinous borderline tumor with microinvasion of the ovary as either borderline (/1) or carcinoma (/3) according to the tumor cell nature. Conclusions: Some issues should be elucidated with the accumulation of more experience and knowledge. Here, however, we present our second proposal.
Abstract
Background: Cancer registration in Korea has a longer than 30-years of history, during which time cancer registration has improved and become well-organized. Cancer registries are fundamental for cancer control and multi-center collaborative research. However, there have been discrepancies in assigning behavior codes. Thus, we intend to propose appropriate behavior codes for the International Classification of Disease Oncology, 3rd edition (ICD-O-3) for microinvasive tumors of the ovary and breast not only to improve the quality of the cancer registry but also to prevent conflicts. Methods: As in series I, two pathology study groups and the Cancer Registration Committee of the Korean Society of Pathologists (KSP) participated. To prepare a questionnaire on provisional behavior code, the relevant subjects were discussed in the workshop, and consensus was obtained by convergence of opinion from members of KSP. Results: Microinvasive tumor of the breast should be designated as a microinvasive carcinoma which was proposed as malignant tumor (/3). Serous borderline tumor with microinvasion of the ovary was proposed as borderline tumor (/1), and mucinous borderline tumor with microinvasion of the ovary as either borderline (/1) or carcinoma (/3) according to the tumor cell nature. Conclusions: Some issues should be elucidated with the accumulation of more experience and knowledge. Here, however, we present our second proposal.
참고문헌 (30)
- Hai-Rim Shin, "Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database", Cancer Research and Treatment, 37(6), pp.325~331 (2005), 대한암학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008", Cancer Research and Treatment, 43(1), pp.1~11 (2011), 대한암학회
- Fritz A, "International classification of diseases for oncology. 3rd ed" (2000), World Health Organization
- World Health Organization, "Manual of the international statistical classification of diseases, injuries, and causes of death. 10th rev" (1992), World Health Organization
- 조미연, "병리의사를 위한 소화기계 암등록에 대한 제안(Ⅰ)", The Korean Journal of Pathology, 42(3), pp.140~150 (2008), 대한병리학회
- Cavaliere A, "Ductal carcinoma in situ with microinvasion: clinicopathologic study and biopathologic profile", Pathol Res Pract, 202, pp.131~135 (2006)
- Schwartz GF, "Nonpalpable in situ ductal carcinoma of the breast: predictors of multicentricity and microinvasion and implications for treatment", Arch Surg, 124, pp.29~32 (1989)
- Solin LJ, "Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation", Int J Radiat Oncol Biol Phys, 23, pp.961~968 (1992)
- Silverstein MJ, "Axillary lymphadenectomy for intraductal carcinoma of the breast", Surg Gynecol Obstet, 172, pp.211~214 (1991)
- Silver SA, "Mammary ductal carcinoma in situ with microinvasion", Cancer, 82, pp.2382~2390 (1998)
- de Mascarel I, "Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas", Cancer, 94, pp.2134~2142 (2002)
- Padmore RF, "Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience", Cancer, 88, pp.1403~1409 (2000)
- Yang M, "Microinvasive ductal carcinoma (T1mic) of the breast: the clinicopathological profile and immunohistochemical features of 28 cases", Pathol Int, 53, pp.422~428 (2003)
- Zavagno G, "Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion", Breast, 16, pp.146~151 (2007)
- McKenney JK, "Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion", Am J Surg Pathol, 30, pp.1209~1221 (2006)
- Bell DA, "Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases", Hum Pathol, 21, pp.397~403 (1990)
- Bell DA, "Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis", Cancer, 62, pp.2212~2222 (1988)
- Bell KA, "Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas", Am J Surg Pathol, 25, pp.419~432 (2001)
- Hart WR, "Mucinous tumors of the ovary: a review", Int J Gynecol Pathol, 24, pp.4~25 (2005)
- Riopel MA, "Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas", Am J Surg Pathol, 23, pp.617~635 (1999)
- Kim KR, "Is stromal microinvasion in primary mucinous ovarian tumors with “mucin granuloma” true invasion?", Am J Surg Pathol, 31, pp.546~554 (2007)
- Fleming ID, "AJCC cancer staging manual. 5th ed" (1997), Springer-Verlag
- Ellis IO, "Microinvasive carcinoma, In World Health Organization classification of tumors: pathology and genetics of tumours of the breast and female genital organs", pp.74~75 (2003), IARC press
- Rosen PP, "Rosen’s breast pathology. 3rd ed", pp.285~357 (2009), Lippincott Williams & Wilkins
- Serov SF, "International histological classification of tumours: histologic typing of ovarian tumors", pp.17~54 (1973), World Health Organization
- Robboy SJ, "Robboy’s pathology of the female reproductive tract. 2nd ed", pp.2009, Churchill Livingstone
- Shih IeM, "Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis", Am J Pathol, 164, pp.1511~1518 (2004)
- Hart WR, "Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential)", Hum Pathol, 8, pp.541~549 (1977)
- Hoerl HD, "Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up", Am J Surg Pathol, 22, pp.1449~1462 (1998)
- Caduff RF, "Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors", Am J Surg Pathol, 23, pp.323~328 (1999)